Antidepressant Addiction, SSRI Addiction, Benzodiazepine Addiction, Point of





We Can Help You Regain Your Life

Point of return is a 501 (c) 3 non-profit that has helped people worldwide to reclaim their life from a dependence to Sleeping Pills, Benzodiazepines and all types of Antidepessants -- We can also Help you.

No reason to suffer, we are prescription drug experts with over eleven years of experience. Our skill is unmatched and our calming nutraceuticals are proven. Let us expertly walk you through the process.




Why Point of Return

Skill - Our non-profit has over eleven years of success helping people withdraw and recover.

Commitment - Our team is compassionate, caring and the staff at Point of Return has their own story of addiction and recovery.

Safe - We offer safe, doctor-written tapering rates and a well-rounded program that keeps you safe during the withdrawal process.

At-Home - You taper in the comfort of your home - this is a gentle process.

Healthy Approach - We utilize specialized all-natural nutraceuticals that help ease the withdrawal symptoms.


People We've Helped

"Point of Return was a vessel sent by God to end my anguish and hell from SSRIs." - Mike E., (Missouri) Paroxetine (Paxil)

"I owe everyone at Point of Return a huge THANK YOU for the support and guidance that led to my success in getting off the Ativan." - William T., (California) Ativan

"I am now free from drugs thanks to this program." - Paula V., (Canada) Celexa


"I did thorough research on my options and considered Point of Return the most knowledgeable and cost effective of all the choices." - Eric S., (California) Temazepam

"I am incredibly grateful to God for leading me to Point of Return 2 years ago, for Alesandra and Andrea and Terry who tirelessly give of themselves to people like me – people who feel hopeless and helpless and stuck" - Bianca (South Africa) Zolpidem, Lexamil

Point of Return in the News

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


Medical Professionals

clonazepam withdrawalHealthcare and physician information MORE...

Recent News

FDA requires strong warnings for opioid and benzodiazepine labeling related to serious risks and death from combining

After an extensive review of the latest scientific evidence, the U.S. Food and Drug Administration announced today that it is requiring class-wide changes to drug labeling, including patient information, to help inform health care providers and patients of the serious risks associated with the combined use of certain opioid medications and a class of central nervous system (CNS) depressant drugs called benzodiazepines.... More